| Neoadjuvant Treatment of Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma (NCT05947201) | Weijia Fang, MD | 2023-05-08 |
| Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL) (NCT05976997) | Liling Zhang | 2023-05-08 |
| Zanubrutinib and Venetoclax as Initial Therapy for Chronic Lymphocytic Leukemia (CLL) With Response-based Obinutuzumab (NCT05650723) | Weill Medical College of Cornell University | 2023-05-08 |
| Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy (NCT05574504) | AdventHealth | 2023-05-08 |
| Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome (NCT05419011) | National Cancer Institute (NCI) | 2023-05-08 |
| Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above (NCT05856084) | MAXVAX Biotechnology Limited Liability Company | 2023-05-07 |
| Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy (NCT05836753) | Beijing Tiantan Hospital | 2023-05-07 |
| Selinexor、Venetoclax and Azactidine in the Treatment of ND AML Patients Who Are Not Eligible for Intense Chemotherapy (NCT06449482) | Institute of Hematology & Blood Diseases Hospital, China | 2023-05-05 |
| A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (NCT05658003) | Novartis Pharmaceuticals | 2023-05-05 |
| A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable MTM HCC (NCT05839197) | Wan-Guang Zhang | 2023-05-05 |
| Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV (NCT05551273) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-05-05 |
| Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma (NCT05913414) | Sun Yat-sen University | 2023-05-05 |
| Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords (NCT05688488) | Eye & ENT Hospital of Fudan University | 2023-05-05 |
| Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors (NCT05662852) | ABO Holdings, Inc. | 2023-05-05 |
| GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence (NCT05557578) | Zhejiang Cancer Hospital | 2023-05-05 |
| Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in (NCT05198479) | National Cancer Centre, Singapore | 2023-05-05 |
| Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial) (NCT05642572) | SWOG Cancer Research Network | 2023-05-05 |
| A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors (NCT05773820) | Wigen Biomedicine Technology (Shanghai) Co., Ltd. | 2023-05-05 |
| Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS) (NCT05563558) | Fundacion Oncosur | 2023-05-05 |
| Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML) (NCT05580601) | Children's Hospital Medical Center, Cincinnati | 2023-05-05 |
| Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years (NCT05866536) | Massachusetts General Hospital | 2023-05-04 |
| Xeomin vs Botox for Treatment of Overactive Bladder Syndrome (NCT06034288) | Walter Reed National Military Medical Center | 2023-05-04 |
| A Study to Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors (NCT05661578) | Hoffmann-La Roche | 2023-05-04 |
| Protect the Head to Head Study (NCT05684146) | Emboline | 2023-05-04 |
| TRUDI: TDXD+Durva in HER2+/Low IBC (NCT05795101) | Filipa Lynce, MD | 2023-05-04 |
| Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity (NCT05760248) | 10xBio, LLC | 2023-05-04 |
| STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER) (NCT05716516) | Dartmouth-Hitchcock Medical Center | 2023-05-04 |
| RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT (NCT05858814) | Guangdong Ruishun Biotech Co., Ltd | 2023-05-04 |
| Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients with Post-COVID Syndrome (NCT05682560) | StemCyte, Inc. | 2023-05-04 |
| Baricitinib in Idiopathic Granulomatous Mastitis (NCT05852171) | First Affiliated Hospital of Zhejiang University | 2023-05-04 |
| Effect of Oral 6-bromotryptophan on Safety, Pharmacokinetics and Efficacy in Metabolic Syndrome Individuals (NCT05971524) | Nordin Hanssen | 2023-05-04 |
| A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) or Pneumonia (NCT05815485) | The University of Texas Medical Branch, Galveston | 2023-05-04 |
| Clavulanic Acid for the Treatment of Cocaine Use Disorder (NCT05562349) | Temple University | 2023-05-03 |
| FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer (NCT05627635) | City of Hope Medical Center | 2023-05-03 |
| A Clinical Trial to Investigate the Safety and Efficacy of D-Mannose on Symptoms of Urinary Tract Infection in Women (NCT06719115) | KEB Nutraceuticals USA, Inc. | 2023-05-03 |
| CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics (NCT05260528) | Centre Hospitalier Universitaire de Nice | 2023-05-03 |
| Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma (NCT05723055) | University of Utah | 2023-05-03 |
| Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia (NCT05592015) | Jonathan Brammer | 2023-05-03 |
| Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (NCT05405387) | University of Utah | 2023-05-03 |
| A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have (NCT05831176) | Regeneron Pharmaceuticals | 2023-05-03 |
| Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis (NCT05740722) | Haukeland University Hospital | 2023-05-03 |
| Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC (NCT05918328) | Henan Cancer Hospital | 2023-05-03 |
| A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis (NCT05870865) | Formation Bio, Inc. | 2023-05-03 |
| A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis (NCT05265325) | Kind Pharmaceuticals LLC | 2023-05-03 |
| Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease (NCT05797506) | University of Rochester | 2023-05-03 |
| Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN) (NCT06120582) | Biocad | 2023-05-02 |
| Evaluation of Tonabersat for DME (NCT05727891) | Jaeb Center for Health Research | 2023-05-02 |
| Myopia Control: a Comparison Study Between Atropine and MiSight (NCT05815784) | Ann & Robert H Lurie Children's Hospital of Chicago | 2023-05-02 |
| Effect of the Administration of L-arginine vs. Placebo in Patients Diagnosed With Presbyvestibulopathy. (NCT05932979) | Centro Universitario de Tonalá | 2023-05-02 |
| Ischemic Conditioning to Promote Microvascular Resiliency in Frail Individuals (NCT05808686) | Medical College of Wisconsin | 2023-05-02 |
| Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia (NCT05734495) | Dana-Farber Cancer Institute | 2023-05-02 |
| A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (NCT05839041) | Aviceda Therapeutics, Inc. | 2023-05-02 |
| A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis (NCT05896527) | DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company | 2023-05-02 |
| Tdap and Biomarkers of Alzheimer's Disease (NCT05183516) | Mindful Diagnostics and Therapeutics, LLC | 2023-05-01 |
| Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome (NCT04213274) | R-Pharm Overseas, Inc. | 2023-05-01 |
| Toripalimab in Combination With Chemotherapy and Antiangiogenic Agents in Patients With Non-Small Cell Lung Cancer After Failure of Immunotherapy (PD-1/L1 Inhibitors) (NCT05842018) | Tianjin Medical University Cancer Institute and Hospital | 2023-05-01 |
| Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA (NCT05855083) | Omeros Corporation | 2023-05-01 |
| Assessment of the Efficacy and Safety of Pembrolizumab for Ovarian Squamous Cell Carcinoma (NCT05737199) | Niigata University Medical & Dental Hospital | 2023-05-01 |
| Efficacy and Safety of Terbinafine and Itraconazole (NCT05881980) | Dhaka Medical College | 2023-05-01 |
| Chidamide Combined With Fulvestrant for HR+/HER2-advanced Breast Cancer (NCT05808582) | The First Affiliated Hospital with Nanjing Medical University | 2023-05-01 |
| Effect Of Ophiochepalus Striatus Extract On Serum IGF-1 And IL-6 Levels In Elderly Patients With Sarcopenia (NCT05869383) | Universitas Sriwijaya | 2023-05-01 |
| Evaluation of the Curative Effect of Ru-Yi-Jin-Huang-Saan (NCT05638360) | Changhua Christian Hospital | 2023-05-01 |
| A Clinical Study of Injectable IMM0306 in Combination With Lenalidomide (NCT05771883) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2023-05-01 |
| GRoningen Early-PD Ambroxol Treatment (NCT05830396) | University Medical Center Groningen | 2023-05-01 |
| To Evaluate Efficacy of Monotherapy of Oxcarbazepine Versus Combination of Gabapentin With Oxcarbazepine in the Management of Trigeminal Neuralgia (NCT07625410) | Rehman Medical Institute - RMI | 2023-05-01 |
| The Effect of Vitamin D3 Supplementation on Hepcidin and Ferritin Serum Levels in Children With Chronic Kidney Disease (NCT06706271) | Hasanuddin University | 2023-05-01 |
| Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn (NCT06860399) | Damascus University | 2023-05-01 |
| The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy (NCT05640726) | Fujian Cancer Hospital | 2023-05-01 |
| Dalpiciclib Plus Fulvestrant With Pyrotinib in Hormone Receptor-positive, HER2-low Advanced Breast Cancer That Progressed on Previous CDK4/6i Plus AI Therapy (NCT05806671) | Tianjin Medical University Cancer Institute and Hospital | 2023-05-01 |
| Disitamab Vedotin Combined Therapy for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations (NCT05847764) | Sun Yat-sen University | 2023-05-01 |
| Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion (NCT05807984) | Xin Cai | 2023-05-01 |
| Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer (NCT05203913) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2023-05-01 |
| Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicular Lymphoma (NCT05152459) | City of Hope Medical Center | 2023-05-01 |
| Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma (NCT05833893) | Chinese PLA General Hospital | 2023-05-01 |
| Coenzyme Q10 in Juvenile Idiopathic Arthritis Patients (NCT05871086) | Nourhan Elsherif | 2023-05-01 |
| Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma (NCT05776407) | Chongqing University Cancer Hospital | 2023-05-01 |
| To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdose (NCT05557448) | Sinew Pharma Inc. | 2023-05-01 |
| Effect of Palmitoylethanolamide on Reducing Opioid Consumption for Below Knee Fracture Fixation (NCT05317676) | University of California, Irvine | 2023-05-01 |
| FOLFOX-HAIC as Conversion Treatment for Initially Unresectable Colorectal Liver Metastasis (NCT06988852) | Tongji Hospital | 2023-05-01 |
| Preoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma (SPARE-03) (NCT05938374) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-05-01 |
| Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (NCT04881682) | University of Ulm | 2023-05-01 |
| Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients (NCT05638451) | Zhujiang Hospital | 2023-05-01 |
| ImPROving Quality of LIFe in the Long COVID Patient (NCT05823896) | Karolinska Institutet | 2023-05-01 |
| Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy (NCT05877911) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-05-01 |
| Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma (NCT05588648) | MedPacto, Inc. | 2023-05-01 |
| PSMA PET Scan and mpMRI for Prostate Cancer Detection (NCT05820724) | VA Greater Los Angeles Healthcare System | 2023-05-01 |
| Phage Therapy for the Treatment of Urinary Tract Infection (NCT05537519) | Unity Health Toronto | 2023-05-01 |
| Lidocaine Patches Prior to Percutaneous Nerve Evaluation (NCT05783219) | University of Louisville | 2023-05-01 |
| Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy (NCT05803915) | Peking Union Medical College Hospital | 2023-05-01 |
| Fruquintinib Plus Serplulimab as First-Line Therapy for Metastatic Non-Clear Cell Renal Cell Carcinoma (NCT05831891) | RenJi Hospital | 2023-05-01 |
| 177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer (NCT06250244) | Peking Union Medical College Hospital | 2023-05-01 |
| Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients (NCT05432778) | University Medical Centre Ljubljana | 2023-05-01 |
| Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia (NCT05990400) | Indonesia University | 2023-05-01 |
| To Evaluate the Clinical Efficacy and Safety of Recombinant Human Interferon ω Spray in Treatment of Viral Upper Respiratory Tract Infection in Children (NCT05859984) | Seventh Medical Center of PLA General Hospital | 2023-05-01 |
| Treatment of Post-Punch Biopsy Bleeding in Anticoagulated Patients Using Self-Administered BXP154 (NCT05837338) | Bio 54, LLC | 2023-05-01 |
| 68Ga-NY104 PET/CT in Von Hippel-Lindau Disease (NCT05810246) | Peking Union Medical College Hospital | 2023-05-01 |
| CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Microsatellite Stable Locally Advanced Rectal Cancer (NCT05585814) | Shanghai Changzheng Hospital | 2023-05-01 |
| Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment (NCT05717582) | Fudan University | 2023-05-01 |
| Cadonilimab Monotherapy as Neoadjuvant Therapy for Resectable II-IIIA Squamous Cell Lung Cancer (NCT05784974) | The First Hospital of Jilin University | 2023-05-01 |
| Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors (NCT06022289) | Tianjin Medical University Second Hospital | 2023-05-01 |